DcR1 Antibodies

Santa Cruz Biotechnology provides a broad selection of DcR1 monoclonal antibodies for advanced research in cell signaling and apoptosis. DcR1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DcR1, or Decoy Receptor 1, plays a critical role in regulating apoptosis by binding to death ligands, thereby inhibiting pro-apoptotic signals. This function is essential for maintaining cellular homeostasis and preventing excessive cell death, which can lead to various diseases, including cancer. Understanding DcR1's role in cellular processes is crucial for developing therapeutic strategies targeting apoptotic pathways. Researchers can investigate DcR1's involvement in various cellular pathways using specific detection methods such as western blotting (WB) and immunofluorescence (IF). Advanced visualization techniques like flow cytometry (FCM) enable detailed analysis of DcR1 expression patterns in different cell populations. Quantitative assessment through enzyme-linked immunosorbent assay (ELISA) provides precise measurements of DcR1 levels in biological samples. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of cell death mechanisms and potential therapeutic applications.